查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1797022

生物安全櫃市場－全球產業規模、佔有率、趨勢、機會和預測（按類型、最終用戶、地區和競爭細分，2020-2030 年）

Biological Safety Cabinet Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented by Type, By End User, By Region and Competition, 2020-2030F
出版日期: | 出版商: TechSci Research | 英文 180 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

簡介目錄

2024 年全球生物安全櫃市場價值為 2.8726 億美元，預計到 2030 年將達到 4.5587 億美元，預測期內的複合年成長率為 8.00%。全球生物安全櫃市場正在經歷顯著成長，這得益於傳染病風險的上升以及生物技術和製藥公司研發活動的增加。生物安全櫃也稱為生物安全櫃。它是一個封閉的通風工作空間，可以安全地處理受病原體污染的元素，這需要指定的生物安全等級。其他支持市場成長的因素包括對治療慢性病的個人化醫療的需求不斷成長，以及患有慢性病的老齡人口不斷成長。此外，醫療領域研發活動的增加和各種新技術的採用率上升也是市場成長的因素。

市場概覽
預測期 2026-2030
2024年市場規模 2.8726億美元
2030年市場規模 4.5587億美元
2025-2030 年複合年成長率 8.00%
成長最快的領域 診斷和檢測實驗室
最大的市場 北美洲

關鍵市場促進因素

提高病原體研究中實驗室生物安全意識

主要市場挑戰

高昂的初始成本和營運成本

主要市場趨勢

智慧、節能的 BSC 設計創新

目錄

第 1 章：產品概述

第2章：研究方法

第3章：執行摘要

第4章：顧客之聲

第5章：全球生物安全櫃市場展望

  • 市場規模和預測
    • 按價值
  • 市場佔有率和預測
    • 依類型（I類、II類、III類）
    • 按最終用戶（製藥和生物製藥公司、診斷和檢測實驗室、學術和研究組織）
    • 按地區
    • 按公司分類（2024）
  • 市場地圖
    • 按類型
    • 按最終用戶
    • 按地區

第6章：北美生物安全櫃市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • 北美：國家分析
    • 美國
    • 加拿大
    • 墨西哥

第7章：歐洲生物安全櫃市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • 歐洲：國家分析
    • 法國
    • 德國
    • 英國
    • 義大利
    • 西班牙

第8章：亞太生物安全櫃市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • 亞太地區：國家分析
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲

第9章：南美洲生物安全櫃市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • 南美洲：國家分析
    • 巴西
    • 阿根廷
    • 哥倫比亞

第10章：中東與非洲生物安全櫃市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • MEA：國家分析
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國

第 11 章：市場動態

  • 驅動程式
  • 挑戰

第 12 章：市場趨勢與發展

  • 最新動態
  • 產品發布
  • 併購

第 13 章：波特五力分析

  • 產業競爭
  • 新進入者的潛力
  • 供應商的力量
  • 顧客的力量
  • 替代產品/服務的威脅

第 14 章：全球生物安全櫃市場：SWOT 分析

第 15 章：競爭格局

  • Thermo Fisher Scientific, Inc.
  • Labconco Corp.
  • NuAire, Inc.
  • The Baker Company, Inc.
  • Haier Biomedical (Qingdao Biomedical Co., Ltd.)
  • Cruma SA
  • Jinan Biobase Biotech Co. Ltd.
  • Azbil Telstar
  • Germfree Laboratories, Inc.
  • Air Science, Inc.

第 16 章：策略建議

第17章調查會社について,免責事項

簡介目錄
Product Code: 14330

Global Biological Safety Cabinet Market was valued at USD 287.26 million in 2024 and is expected to reach USD 455.87 million by 2030 with a CAGR of 8.00% during the forecast period. The global market for Biological Safety Cabinet is experiencing significant growth, driven by the rising risk of communicable diseases and increasing research and development activities in biotechnology and pharmaceutical companies. Biological Safety Cabinets is also known as biosafety cabinets. It is an enclosed ventilated workspace that enables safety working with elements contaminated with pathogens, which requires a designated biosafety level. The other factors supporting the market's growth are the growing demand for personalized medicine for the treatment of chronic diseases, and the growing aging population with chronic diseases. Moreover, the rise in the research and development activities in the medical sector and the rise in the adoption of various new technologies are the contributing factors to the growth of the market.

Market Overview
Forecast Period2026-2030
Market Size 2024USD 287.26 Million
Market Size 2030USD 455.87 Million
CAGR 2025-20308.00%
Fastest Growing SegmentDiagnostics & Testing Laboratories
Largest MarketNorth America

Key Market Drivers

Escalating Awareness of Lab Biosafety in Pathogen Research

The recent focus on high-risk pathogen handling-especially following outbreaks such as COVID 19, Ebola, and anthrax lapses-has catalyzed a global push towards safer laboratory environments. Biosafety cabinets are central to these efforts, offering primary containment to reduce staff exposure and environmental pollution. In the United States, repeated audits by the CDC and Department of Health have highlighted biosafety lapses, prompting reforms and procedural overhauls. International bodies such as the World Health Organization (WHO) also stress strict biosafety practices. For example, in 2023 WHO supported certification training in Nepal to strengthen national biosafety capacity. As pandemic preparedness becomes a policy priority, national health agencies are investing in BSCs-especially Class II and III-to ensure safe handling of emerging pathogens. Such measures align with recommended biosafety upgrade plans and global health compliance frameworks, boosting BSC market demand.

Key Market Challenges

High Initial and Operational Costs

Despite regulatory backing, cost remains a barrier for many laboratories. Advanced Class II and III units-with HEPA filters, air handling ducting, and smart electronics-can be prohibitively expensive, especially in resource-limited settings. Even after purchase, recurring costs related to HEPA filter replacements, airflow testing equipment, and annual NSF/ANSI certifications add up.

Improper or inadequate installation, lack of trained personnel, and budget constraints can reduce compliance. As noted in Southeast Asian labs, ~30% of BSCs were found to be mis installed or improperly maintained. Without sustained funding, especially in low-income institutions, these safety-critical systems may lapse into disuse or underperformance-posing regulatory and biohazard risks.

Key Market Trends

Innovation in Smart, Energy-Efficient BSC Designs

A major ongoing trend is the rise of smart, energy-efficient biosafety cabinets. Manufacturers are integrating digital airflow monitoring, automated sash control, and IoT-enabled alerts for filter replacement or airflow disruptions. Some advanced models self-adjust airflow when idle, reducing energy usage by up to 30%, along with LED lighting and efficient motors that further cut operating costs.

Cabinets designed to fit in space-constrained microbiology or pharmaceutical labs-often with laminar and containment airflow modes-are gaining popularity. These smart and sustainable innovations align with institutional goals to improve safety while minimizing carbon footprint and operational expense, signaling a shift toward eco-conscious laboratory design.

Key Market Players

  • Thermo Fisher Scientific, Inc.
  • Labconco Corp.
  • NuAire, Inc.
  • The Baker Company, Inc.
  • Haier Biomedical (Qingdao Biomedical Co., Ltd.)
  • Cruma S.A.
  • Jinan Biobase Biotech Co. Ltd.
  • Azbil Telstar
  • Germfree Laboratories, Inc.
  • Air Science, Inc.

Report Scope:

In this report, the Global Biological Safety Cabinet Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Biological Safety Cabinet Market, By Type:

  • Class I
  • Class II
  • Class III

Biological Safety Cabinet Market, By End User:

  • Pharmaceutical & Biopharmaceutical Companies
  • Diagnostics & Testing Laboratories
  • Academic & Research Organizations

Biological Safety Cabinet Market, By Region:

  • North America
    • United States
    • Mexico
    • Canada
  • Europe
    • France
    • Germany
    • United Kingdom
    • Italy
    • Spain
  • Asia-Pacific
    • China
    • India
    • South Korea
    • Japan
    • Australia
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East and Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies presents in the Global Biological Safety Cabinet Market.

Available Customizations:

Global Biological Safety Cabinet Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Biological Safety Cabinet Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Type (Class I, Class II, Class III)
    • 5.2.2. By End User (Pharmaceutical & Biopharmaceutical Companies, Diagnostics & Testing Laboratories, Academic & Research Organizations)
    • 5.2.3. By Region
    • 5.2.4. By Company (2024)
  • 5.3. Market Map
    • 5.3.1. By Type
    • 5.3.2. By End User
    • 5.3.3. By Region

6. North America Biological Safety Cabinet Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Type (Class I, Class II, Class III)
    • 6.2.2. By End User (Pharmaceutical & Biopharmaceutical Companies, Diagnostics & Testing Laboratories, Academic & Research Organizations)
    • 6.2.3. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Biological Safety Cabinet Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Type
        • 6.3.1.2.2. By End User
    • 6.3.2. Canada Biological Safety Cabinet Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Type
        • 6.3.2.2.2. By End User
    • 6.3.3. Mexico Biological Safety Cabinet Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Type
        • 6.3.3.2.2. By End User

7. Europe Biological Safety Cabinet Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Type (Class I, Class II, Class III)
    • 7.2.2. By End User (Pharmaceutical & Biopharmaceutical Companies, Diagnostics & Testing Laboratories, Academic & Research Organizations)
    • 7.2.3. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. France Biological Safety Cabinet Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Type
        • 7.3.1.2.2. By End User
    • 7.3.2. Germany Biological Safety Cabinet Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Type
        • 7.3.2.2.2. By End User
    • 7.3.3. United Kingdom Biological Safety Cabinet Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Type
        • 7.3.3.2.2. By End User
    • 7.3.4. Italy Biological Safety Cabinet Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Type
        • 7.3.4.2.2. By End User
    • 7.3.5. Spain Biological Safety Cabinet Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Type
        • 7.3.5.2.2. By End User

8. Asia-Pacific Biological Safety Cabinet Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Type (Class I, Class II, Class III)
    • 8.2.2. By End User (Pharmaceutical & Biopharmaceutical Companies, Diagnostics & Testing Laboratories, Academic & Research Organizations)
    • 8.2.3. By Country
  • 8.3. Asia-Pacific: Country Analysis
    • 8.3.1. China Biological Safety Cabinet Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Type
        • 8.3.1.2.2. By End User
    • 8.3.2. India Biological Safety Cabinet Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Type
        • 8.3.2.2.2. By End User
    • 8.3.3. Japan Biological Safety Cabinet Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Type
        • 8.3.3.2.2. By End User
    • 8.3.4. South Korea Biological Safety Cabinet Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Type
        • 8.3.4.2.2. By End User
    • 8.3.5. Australia Biological Safety Cabinet Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Type
        • 8.3.5.2.2. By End User

9. South America Biological Safety Cabinet Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Type (Class I, Class II, Class III)
    • 9.2.2. By End User (Pharmaceutical & Biopharmaceutical Companies, Diagnostics & Testing Laboratories, Academic & Research Organizations)
    • 9.2.3. By Country
  • 9.3. South America: Country Analysis
    • 9.3.1. Brazil Biological Safety Cabinet Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Type
        • 9.3.1.2.2. By End User
    • 9.3.2. Argentina Biological Safety Cabinet Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Type
        • 9.3.2.2.2. By End User
    • 9.3.3. Colombia Biological Safety Cabinet Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Type
        • 9.3.3.2.2. By End User

10. Middle East and Africa Biological Safety Cabinet Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Type (Class I, Class II, Class III)
    • 10.2.2. By End User (Pharmaceutical & Biopharmaceutical Companies, Diagnostics & Testing Laboratories, Academic & Research Organizations)
    • 10.2.3. By Country
  • 10.3. MEA: Country Analysis
    • 10.3.1. South Africa Biological Safety Cabinet Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Type
        • 10.3.1.2.2. By End User
    • 10.3.2. Saudi Arabia Biological Safety Cabinet Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Type
        • 10.3.2.2.2. By End User
    • 10.3.3. UAE Biological Safety Cabinet Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Type
        • 10.3.3.2.2. By End User

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Recent Developments
  • 12.2. Product Launches
  • 12.3. Mergers & Acquisitions

13. Porters Five Forces Analysis

  • 13.1. Competition in the Industry
  • 13.2. Potential of New Entrants
  • 13.3. Power of Suppliers
  • 13.4. Power of Customers
  • 13.5. Threat of Substitute Products/Services

14. Global Biological Safety Cabinet Market: SWOT Analysis

15. Competitive Landscape

  • 15.1. Thermo Fisher Scientific, Inc.
    • 15.1.1. Business Overview
    • 15.1.2. Company Snapshot
    • 15.1.3. Products & Services
    • 15.1.4. Financials (As Reported)
    • 15.1.5. Recent Developments
    • 15.1.6. Key Personnel Details
    • 15.1.7. SWOT Analysis
  • 15.2. Labconco Corp.
  • 15.3. NuAire, Inc.
  • 15.4. The Baker Company, Inc.
  • 15.5. Haier Biomedical (Qingdao Biomedical Co., Ltd.)
  • 15.6. Cruma S.A.
  • 15.7. Jinan Biobase Biotech Co. Ltd.
  • 15.8. Azbil Telstar
  • 15.9. Germfree Laboratories, Inc.
  • 15.10. Air Science, Inc.

16. Strategic Recommendations

17. About Us & Disclaimer